Advanced ovarian cancer: the case for personalized treatment

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • Primary debulking surgery (PDS) was associated with improved outcomes, and neoadjuvant chemotherapy (NACT) may improve survival in those with residual disease after PDS.
Why this matters
  • Not all patients with stage III or IV ovarian cancers benefit from 1 standard approach, PDS or NACT, a...